What Does a Lung CT Scan Show? Common Findings

A lung CT scan produces detailed cross-sectional images of your lungs, airways, blood vessels, and surrounding structures, revealing everything from tiny nodules a few millimeters across to large masses, areas of infection, signs of chronic lung disease, blood clots, fluid collections, and scarring. Because CT captures so much anatomical detail, the list of possible findings on a single scan is long, and many of them turn out to be harmless. Understanding what radiologists look for and how they interpret common patterns can help you make sense of a report that might otherwise read like a foreign language.

Lung Nodules

Lung nodules are among the most frequently reported findings on chest CT, and they are also one of the most anxiety-inducing for patients. A nodule is simply a small, roughly round spot in the lung tissue. The vast majority are benign, caused by old infections, small lymph nodes, or minor areas of scarring. But because a small percentage turn out to be early-stage lung cancer, radiologists evaluate every nodule carefully.

Several features help distinguish worrisome nodules from harmless ones. Size matters: the bigger a nodule, the higher its chance of being malignant, and current guidelines from the Fleischner Society raised the minimum threshold size for recommending routine follow-up, acknowledging that very small nodules rarely turn out to be cancer.¹ Shape also matters. A nodule with smooth, well-defined borders and a polygonal shape is more likely benign, while features like lobulation, spiculated margins, and pleural retraction raise suspicion for malignancy.² Additional clues like calcification, satellite lesions, and a surrounding halo sign tend to point toward a benign cause, while the absence of these features and the presence of air bronchograms or bronchial truncation lean toward cancer.²

Beyond shape and size, radiologists pay close attention to density. A solid nodule is uniformly opaque on the scan. A ground-glass nodule looks hazy, like frosted glass, because it only partially fills the air spaces. A part-solid nodule has both components. Subsolid nodules (ground-glass and part-solid combined) carry a relatively high risk of being malignant, but when they are malignant they tend to behave in a slow, indolent way.³ For part-solid nodules specifically, a well-defined border, lobulation of the whole nodule, and an irregularly shaped or scattered internal solid component were all strong predictors of malignancy.⁴ For pure ground-glass nodules, a higher average density and a well-defined border favor malignancy as well.⁵

When a nodule is found, follow-up recommendations depend on its size, density, whether it is a single nodule or one of many, and your personal risk factors like smoking history and age. The updated Fleischner guidelines give follow-up intervals as a range rather than a single fixed date, allowing doctors and patients some flexibility based on individual circumstances.⁶ A tiny solid nodule under about 6 mm in a low-risk patient may not need any follow-up at all. A larger or growing nodule, or one with suspicious features, typically warrants a repeat scan in a few months or a biopsy.

Ground-Glass Opacities and Consolidation

Ground-glass opacity, or GGO, is one of the terms you are most likely to encounter on a lung CT report. It describes any area where the lung tissue looks hazy but you can still see the blood vessels and airways running through it. GGO is not a diagnosis by itself; it is a pattern that shows up in dozens of conditions, from infections to inflammation to early cancer to fluid overload. The location, distribution, and accompanying findings are what narrow down the cause.

COVID-19 made GGO a household term. The typical CT findings of COVID-19 pneumonia are bilateral ground-glass opacities concentrated toward the outer edges of the lungs.⁷ In a study of patients hospitalized with COVID pneumonia, ground-glass opacity appeared in nearly all cases, followed by a “crazy-paving” pattern in about 58% and consolidation in about 10%, with the abnormalities predominantly bilateral, in the lower lobes, and toward the back of the lungs.⁸ But it is worth remembering that many other infections, as well as non-infectious conditions like drug reactions, pulmonary hemorrhage, and heart failure, can create similar hazy patterns. A radiologist reading your scan considers the clinical context, not just the image alone.

Consolidation is the denser sibling of GGO. When lung tissue fills so completely with fluid, pus, or cells that you can no longer see the vessels through it, that area appears as a bright white patch. This is the classic appearance of bacterial pneumonia, though it also shows up in fungal infections, organizing pneumonia, and some cancers. When air-filled bronchi remain visible running through a consolidated area, radiologists call this an “air bronchogram sign.” In pneumonia, the airways within the consolidation tend to appear normal in shape, while in lung cancer or organizing pneumonia the bronchi are more likely to look distorted or narrowed.⁹

The Tree-in-Bud Pattern and Airway Infections

Some infections leave a distinctive calling card on CT known as the “tree-in-bud” pattern: tiny branching opacities at the very ends of the airways that resemble a budding tree limb. This pattern reflects inflammation and plugging of the smallest bronchioles, and it was first described in tuberculosis spreading within the airways.¹⁰ Since then, it has been recognized in bacterial, fungal, viral, and parasitic infections, as well as aspiration of foreign material, certain immune disorders, and even some vascular diseases.¹⁰ Although infection remains the dominant cause, the pattern is not exclusive to it.¹¹

In children, certain infections like Mycoplasma pneumonia can look surprisingly similar to classic bacterial pneumonia on CT, with lobar consolidation, pleural effusion, and enlarged lymph nodes.¹² In adults, the same organism tends to produce a different picture: diffuse or patchy ground-glass areas centered around the small airways, with thickened airway walls.¹² These age-related differences in the same infection illustrate why the same organism does not always produce the same CT appearance.

Emphysema and Chronic Airway Disease

Emphysema shows up on CT as areas of abnormally low density in the lung, where the tiny air sacs have been permanently destroyed. Radiologists classify emphysema into three main types based on where the damage sits within the lung’s microscopic architecture. Centrilobular emphysema, the most common type in smokers, appears as scattered tiny dark spots with ill-defined borders. Panlobular emphysema produces a more diffuse darkening of the entire lung region and is associated with alpha-1 antitrypsin deficiency as well as severe smoking. Paraseptal emphysema shows up as small well-defined cystic spaces along the outer edges of the lung, near the pleural surfaces.¹³

These subtypes are not just academic distinctions. In a study comparing smokers with different emphysema patterns, people with centrilobular or panlobular emphysema had worse shortness of breath, shorter walking distances, greater lung hyperinflation, and lower diffusing capacity compared to those without emphysema. Those with paraseptal emphysema alone, however, were functionally similar to people without any emphysema at all.¹⁴ And the visual severity matters for prognosis: in a large study, mortality rose progressively from mild to confluent emphysema, with adjusted hazard ratios climbing from about 1.7 for mild centrilobular emphysema to 5.0 for confluent emphysema compared to people with no visible emphysema.¹⁵

Bronchiectasis is another chronic airway finding that CT detects well. It refers to permanently widened airways that have lost their normal ability to taper as they branch outward. On CT, the hallmark is a bronchus (airway tube) that is wider than the adjacent blood vessel, sometimes described as the “signet ring” sign. CT is the most sensitive imaging tool for detecting this condition.¹¹ It can result from repeated infections, cystic fibrosis, immune deficiencies, or chronic inflammatory conditions, and its distribution on the scan sometimes gives clues to the underlying cause.

Pulmonary Fibrosis and Interstitial Lung Disease

When the lung’s supporting scaffolding gets inflamed or scarred, CT picks up a set of patterns collectively known as interstitial lung disease. The most well-known of these is idiopathic pulmonary fibrosis, or IPF, where the lungs progressively scar for reasons that are still not fully understood. Characteristic CT findings include a fine net-like pattern of lines called reticulation, architectural distortion (the lung’s normal structures look pulled out of shape), and honeycombing, which appears as clusters of small thick-walled cystic spaces. These changes typically concentrate in the lower lobes and the lung periphery.¹⁶

Traction bronchiectasis, where scarring pulls the airways open, is another important sign. Research suggests that in IPF, traction bronchiectasis and honeycombing may actually represent different stages along a single spectrum of progressive lung remodeling rather than entirely separate findings.¹⁷ When a CT shows the classic combination of lower-lobe, peripheral honeycombing with reticulation and traction bronchiectasis, the diagnosis of usual interstitial pneumonia (the pattern most associated with IPF) can often be made with high confidence from the scan alone, without a lung biopsy.

Blood Clots in the Pulmonary Arteries

CT pulmonary angiography, a contrast-enhanced CT specifically designed to visualize the lung’s blood vessels, is the primary tool for diagnosing pulmonary embolism. The key finding is a filling defect: a dark spot within the bright contrast-filled artery, indicating a clot is blocking blood flow. While pulmonary embolism is the most common cause of these filling defects, other conditions like tumors invading or compressing the vessel can sometimes mimic the appearance.¹⁸

In an acute pulmonary embolism, the clot may completely occlude the artery, causing it to appear swollen, or it may partially block it, sitting centrally within the vessel with contrast flowing around it. When the clot is off to one side, it forms sharp angles with the vessel wall. In chronic clots, by contrast, the defect tends to cling to the vessel wall at obtuse angles, and the affected artery may be narrowed rather than enlarged.¹⁹ This distinction matters because acute and chronic emboli require different treatment approaches.

Pleural Findings

The pleura is the thin membrane that lines the lungs and the inside of the chest wall. CT commonly reveals abnormalities in this space. Pleural effusion, a collection of fluid between the two pleural layers, appears as a crescent-shaped density along the dependent (lowest) part of the chest. The causes range widely, from heart failure and liver disease to infection and cancer.²⁰ A pneumothorax, or collapsed lung, shows up as a dark area of free air between the lung surface and the chest wall. Pleural thickening, which looks like a white rind coating the lung surface, can result from old infections, asbestos exposure, systemic diseases, or cancer.²⁰

Pleural plaques deserve a special mention because they are a telltale sign of past asbestos exposure. These are discrete patches of thickened, sometimes calcified tissue on the pleural surface. They tend to appear along the chest wall, on the diaphragm, and along the mediastinum. In a study of people exposed to asbestos from Korean mines, the chest wall was involved in nearly 99% of cases, and diaphragmatic plaques appeared in about 78%, with a right-side preference.²¹ Plaques themselves are benign, but they signal that asbestos exposure occurred, which raises the risk for more serious asbestos-related diseases.

Signs of Pulmonary Hypertension on CT

Even without specialized testing, a standard chest CT can pick up signs that the pressure in the pulmonary arteries is higher than normal. The main pulmonary artery dilates under increased pressure, and a diameter above about 29 mm in men or 27 mm in women is generally considered abnormal.²² Other signs include thickening of the right ventricle’s free wall (above about 6 mm suggests elevated pressure with good accuracy) and dilation of the right ventricle relative to the left. When the right ventricle becomes larger than the left, the dividing wall between them begins to flatten or even bow into the left ventricle, a finding visible on axial CT images.²² These indirect signs do not replace a right heart catheterization for definitive diagnosis, but they can raise a red flag that prompts further evaluation.

Incidental Cardiovascular Findings

A chest CT is aimed at the lungs, but the heart, great vessels, and surrounding structures are captured in every scan. Coronary artery calcification, enlarged heart chambers, pericardial effusion, thoracic aortic aneurysms, and other cardiovascular abnormalities frequently appear as incidental findings, and many of them never make it into the final radiology report because they fall outside the scan’s primary purpose.²³ That is a missed opportunity, because some of these findings carry real prognostic value for future heart disease. Growing awareness of this has led radiology organizations to develop formal guidance on how to handle incidental findings systematically, balancing the benefit of catching something early against the cost and anxiety of unnecessary follow-up.²⁴

What Radiation Therapy Does to Lung CT Appearances

If you have been treated with chest radiation for lung cancer or another thoracic malignancy, your follow-up CT scans will look different from what the untreated lung normally shows. Radiation-induced lung disease follows a predictable timeline. In the acute phase, weeks to a few months after treatment, the irradiated area typically shows ground-glass opacity or consolidation, sometimes extending beyond the radiation field. In the chronic phase, months to years later, the damage evolves into scarring, volume loss, and traction bronchiectasis.²⁵

The patterns of radiation pneumonitis can vary. Some patients develop a localized inflammatory response around the treated tumor, while others show a more diffuse pattern resembling organizing pneumonia, with consolidation in areas far from the original radiation field. A third, more severe pattern looks like acute interstitial pneumonia with widespread patchy opacity.²⁶ Recognizing these as expected post-treatment changes rather than new disease or tumor recurrence is a real challenge, and knowing your treatment history helps your radiologist interpret the images correctly.

Artifacts That Can Fool You

Not everything that appears abnormal on a lung CT is actually abnormal. Motion artifacts from breathing or heartbeat can distort the images in ways that mimic real disease. A well-documented example involves cardiac motion causing the airways near the heart to appear dilated on the scan, creating a false appearance of bronchiectasis.²⁷ This kind of artifact tends to affect the lingula and left lower lobe because they sit closest to the heart. Radiologists familiar with this pitfall can usually spot it by checking whether the “bronchiectasis” is limited to areas immediately adjacent to the heart and whether the patient’s clinical picture makes bronchiectasis unlikely. Streak artifacts from dense structures like bones, metal implants, or contrast material in large veins can also create confusing shadows that overlay the lung tissue. When in doubt, a radiologist may recommend a repeat scan with a different technique to sort artifact from true pathology.

AI as a Second Set of Eyes

Artificial intelligence tools are increasingly being tested and, in some cases, approved to help radiologists read lung CT scans, particularly for nodule detection. The appeal is clear: a human radiologist scanning hundreds of images can miss a subtle small nodule, especially under time pressure. AI systems working as a “second reader” have shown sensitivity above 95% for pulmonary nodule detection, with fewer than one false positive per scan in some evaluations.²⁸ One study found that AI detected all malignancies and achieved a nodule detection sensitivity of over 99%, far exceeding radiologists who caught about 43%, though the AI’s false-positive rate was higher and dropped substantially when nodules smaller than 5 mm were excluded.²⁹

Despite these promising numbers, real-world adoption has been slow. Although several AI tools have received regulatory approval for pulmonary nodule evaluation, integration into daily clinical practice remains limited.³⁰ Concerns include how well algorithms trained on one population perform on different patient groups, how to handle the extra false positives that can lead to unnecessary follow-up scans and biopsies, and liability questions when AI and human readers disagree. For now, AI in lung CT is best understood as a supplement to human expertise rather than a replacement.

Reducing Radiation Dose Without Losing Detail

One practical concern for anyone getting a lung CT, especially if repeat scans are needed for nodule monitoring or cancer screening, is cumulative radiation exposure. Newer scanner technologies and image-processing techniques are steadily pushing doses downward. Iterative reconstruction algorithms and low tube current settings can produce diagnostic-quality images at doses well below traditional protocols.³¹ AI-based denoising is pushing the envelope further, with one study showing that ultra-low-dose scans delivering about 76% less radiation than standard low-dose protocols could still classify nodules into the same risk categories with no meaningful difference in accuracy.³² Photon-counting detector technology, a newer hardware advance, provides less image noise and better stability at low doses compared to conventional detectors, which could further reduce the radiation needed for lung cancer screening.³³

That said, researchers urge caution before aggressively dropping doses to “ultra-low” levels. Most studies testing these extreme reductions have evaluated nodule detection based on size alone, with varying cutoff values, and many excluded obese patients, whose scans are inherently noisier.³¹ Whether ultra-low-dose scans can reliably characterize the subtle features that distinguish benign from malignant nodules, not just detect their presence, is still an open question.